| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
protein tyrosine phosphatase non-receptor type 22 | 0.438 | 0.846 | 3.5E-21 |
|
disease | 0.700 | None | 0.899 | 9 | 4 | 2004 | 2019 | ||||||||
|
major histocompatibility complex, class II, DR beta 1 | 0.333 | 0.923 | 1.1E-03 |
|
disease | 0.500 | None | 0.936 | 6 | 4 | 1989 | 2020 | ||||||||
|
C-C motif chemokine receptor 6 | 0.485 | 0.808 | 5.8E-03 |
|
disease | 0.500 | None | 1.000 | 6 | 8 | 2001 | 2019 | ||||||||
|
testis expressed basic protein 1 | 0.638 | 0.692 | 1.5E-16 |
|
disease | 0.130 | None | 0.889 | 6 | 149 | 2007 | 2019 | ||||||||
|
TSBP1 and BTNL2 antisense RNA 1 | 0.638 | 0.692 |
|
disease | 0.100 | None | 1.000 | 6 | 221 | 2007 | 2014 | |||||||||
|
signal transducer and activator of transcription 4 | 0.471 | 0.769 | 0.77 |
|
disease | 0.500 | None | 0.889 | 5 | 5 | 2000 | 2019 | ||||||||
|
sprouty related EVH1 domain containing 2 | 0.711 | 0.577 | 2.9E-07 |
|
disease | 0.400 | None | 1.000 | 5 | 4 | 2010 | 2019 | ||||||||
|
major histocompatibility complex, class II, DR beta 9 (pseudogene) | 0.682 | 0.654 |
|
disease | 0.100 | None | 1.000 | 5 | 21 | 2007 | 2019 | |||||||||
|
interleukin 2 receptor subunit alpha | 0.389 | 0.885 | 5.5E-02 |
|
disease | 0.500 | None | 1.000 | 4 | 2 | 1992 | 2019 | ||||||||
|
CD40 molecule | 0.396 | 0.846 | 0.85 |
|
disease | 0.500 | None | 0.848 | 4 | 2 | 2002 | 2019 | ||||||||
|
peptidyl arginine deiminase 4 | 0.494 | 0.808 | 4.6E-16 |
|
disease | 0.500 | None | 0.912 | 4 | 6 | 2003 | 2020 | ||||||||
|
TNF receptor associated factor 1 | 0.554 | 0.731 | 3.6E-03 |
|
disease | 0.500 | None | 0.850 | 4 | 2 | 2007 | 2019 | ||||||||
|
REL proto-oncogene, NF-kB subunit | 0.579 | 0.692 | 1.00 |
|
disease | 0.460 | None | 0.909 | 4 | 2 | 2009 | 2019 | ||||||||
|
ankyrin repeat domain 55 | 0.650 | 0.462 | 6.8E-08 |
|
disease | 0.440 | None | 1.000 | 4 | 3 | 2010 | 2019 | ||||||||
|
major histocompatibility complex, class II, DQ alpha 1 | 0.416 | 0.846 | 2.4E-02 |
|
disease | 0.200 | None | 0.962 | 4 | 7 | 1990 | 2016 | ||||||||
|
macrophage immunometabolism regulator | 0.691 | 0.462 | 0.43 |
|
disease | 0.120 | None | 1.000 | 4 | 3 | 2010 | 2019 | ||||||||
|
PHD finger protein 19 | 0.716 | 0.385 | 1.00 |
|
disease | 0.120 | None | 0.857 | 4 | 5 | 2007 | 2019 | ||||||||
|
butyrophilin like 2 | 0.546 | 0.808 | 8.6E-11 |
|
disease | 0.120 | None | 1.000 | 4 | 31 | 2005 | 2013 | ||||||||
|
major histocompatibility complex, class II, DP beta 1 | 0.453 | 0.923 | 5.3E-10 |
|
disease | 0.500 | None | 0.938 | 3 | 62 | 1988 | 2020 | ||||||||
|
NFKB inhibitor like 1 | 0.653 | 0.615 | 2.6E-02 |
|
disease | 0.470 | None | 1.000 | 3 | 4 | 2001 | 2011 | ||||||||
|
AF4/FMR2 family member 3 | 0.623 | 0.692 | 1.00 |
|
disease | 0.460 | None | 1.000 | 3 | 3 | 2009 | 2016 | ||||||||
|
membrane metalloendopeptidase like 1 | 0.606 | 0.692 | 1.2E-22 |
|
disease | 0.440 | None | 0.909 | 3 | 2 | 2008 | 2019 | ||||||||
|
AT-rich interaction domain 5B | 0.638 | 0.500 | 1.00 |
|
disease | 0.410 | None | 1.000 | 3 | 3 | 2012 | 2019 | ||||||||
|
major histocompatibility complex, class II, DQ alpha 2 | 0.617 | 0.769 | 1.0E-05 |
|
disease | 0.400 | None | 1.000 | 3 | 15 | 2007 | 2011 | ||||||||
|
transporter 2, ATP binding cassette subfamily B member | 0.517 | 0.808 | 6.9E-11 |
|
disease | 0.200 | None | 1.000 | 3 | 4 | 1994 | 2016 |